EQUITY RESIDENTIAL shareholders approved Ratification of Independent Registered Public Accounting Firm for 2026 at the 2026-06-18 meeting.
“Proposal 2 – Ratification of Independent Registered Public Accounting Firm for 2026 The selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2026 was ratified by the shareholders, by the votes set forth below. For 334,272,653 Against 19,247,519 Abstain 127,215”
EQREQUITY RESIDENTIAL
EQUITY RESIDENTIAL shareholders approved Election of Trustees at the 2026-06-18 meeting.
“Proposal 1 – Election of Trustees All ten of the nominees for Trustees were elected to serve for a one-year term which expires at the Company’s 2027 annual meeting of shareholders and until their respective successors are duly elected and qualified, by the votes set forth below. Nominee For Against Abstain Angela M. Aman 333,960,226 4,317,821 127,826 Chris Carr 335,162,934 3,115,397 127,542 Mary Kay Haben 318,084,389 20,195,307 126,177 Ann C. Hoff 336,402,370 1,876,589 126,914 Tahsinul Zia Huque 331,073,012 6,594,980 737,881 Nina P. Jones 331,880,618 6,396,918 128,337 David J. Neithercut 326,009,321 12,241,643 154,909 Mark J. Parrell 335,595,693 2,710,521 99,659 Mark S. Shapiro 323,394,266 14,891,087 120,520 Stephen E. Sterrett 332,502,029 5,774,379 129,465 There were 15,241,514 broker non-votes with respect to Proposal 1.”
TWITITAN INTERNATIONAL INC
TITAN INTERNATIONAL INC shareholders approved Non-binding advisory vote on 2025 compensation paid to the named executive officers at the 2026-06-18 meeting.
“Proposal 3: Non-Binding Advisory Vote of the 2025 Compensation Paid to the Named Executive Officers The non-binding advisory resolution on 2025 executive compensation was approved by the following vote: Shares Voted For Shares Against Shares Abstaining Broker Non-Votes 45,170,750 869,022 245,593 5,751,365”
TWITITAN INTERNATIONAL INC
TITAN INTERNATIONAL INC shareholders approved Ratification of the selection of BDO USA P.C. as independent registered public accounting firm to audit the Company's financial statements for the year ending December 31, 2026 at the 2026-06-18 meeting.
“Proposal 2: Ratification of Independent Registered Public Accounting Firm of BDO USA P.C. The selection of BDO USA P.C. as the independent registered public accounting firm to audit the Company's financial statements for the year ending December 31, 2026 was ratified by the following vote: Shares Voted For Shares Against Shares Abstaining Broker Non-Votes 51,744,118 195,441 97,171 —”
TWITITAN INTERNATIONAL INC
TITAN INTERNATIONAL INC shareholders approved Election of Richard M. Cashin Jr., Max A. Guinn, Mark H. Rachesky, MD, Paul G. Reitz, Anthony L. Soave, Maurice M. Taylor Jr. and Laura K. Thompson as directors to serve for one-year terms at the 2026-06-18 meeting.
“Proposal 1: Election of Directors The following nominees for election to the Titan International, Inc. Board of Directors, Mr. Cashin, Mr. Guinn, Dr. Rachesky, Mr. Reitz, Mr. Soave, Mr. Taylor, and Ms. Thompson were duly elected for a one-year term. The number of votes cast for or against (or withheld) and the number of broker non-votes with respect to Proposal 1 voted upon, as applicable, are set forth below: Shares Voted For Shares Withheld Broker Non-Votes Richard M. Cashin Jr. 44,068,840 2,216,525 5,751,365 Max A. Guinn 40,269,790 6,015,575 5,751,365 Mark H. Rachesky, MD 41,892,637 4,392,728 5,751,365 Paul G. Reitz 42,391,804 3,893,561 5,751,365 Anthony L. Soave 44,465,699 1,819,666 5,751,365 Maurice M. Taylor, Jr. 42,483,225 3,802,140 5,751,365 Laura K. Thompson 45,510,648 774,717 5,751,365”
AMWLAmerican Well Corp
American Well Corp shareholders approved Advisory Vote on Named Executive Officer Compensation at the 2026-06-16 meeting.
“Proposal 3 — Advisory Vote on Named Executive Officer Compensation The stockholders of the Company approved, by a non-binding advisory vote, the compensation paid to the company’s named executive officers, as disclosed in the Executive Compensation section and the related compensation tables and narrative disclosure in the proxy statement. The voting results are as follows: For Withheld Broker Non-Votes 21,137,741 326,662 2,507,946”
AMWLAmerican Well Corp
American Well Corp shareholders approved Ratifying the Appointment of the Independent Registered Public Accounting Firm at the 2026-06-16 meeting.
“Proposal 2 — Ratifying the Appointment of the Independent Registered Public Accounting Firm The stockholders of the Company ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The voting results are as follows: For Withheld Broker Non-Votes 23,945,239 27,110 -”
AMWLAmerican Well Corp
American Well Corp shareholders approved Election of Directors at the 2026-06-16 meeting.
“Proposal 1 — Election of Directors The stockholders of the Company elected the following Class III director nominee proposed by the Company’s Board of Directors to serve until the 2029 annual meeting of stockholders of the Company or until his respective successor has been duly elected and qualified. The voting results are as follows: Name For Withheld Broker Non-Votes Dr. Ido Schoenberg 20,509,462 954,941 2,507,946”
WDAYWorkday, Inc.
Workday, Inc. shareholders rejected Stockholder proposal regarding disclosure of voting results based on share class at the 2026-06-16 meeting.
“Stockholders did not approve the stockholder proposal regarding disclosure of voting results based on share class. The voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes 91,053,917 534,484,001 743,963 21,155,889”
WDAYWorkday, Inc.
Workday, Inc. shareholders rejected Stockholder proposal regarding disclosure of employee retention rates by demographic category at the 2026-06-16 meeting.
“Stockholders did not approve the stockholder proposal regarding disclosure of employee retention rates by demographic category. The voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes 22,915,097 602,186,490 1,180,294 21,155,889”
WDAYWorkday, Inc.
Workday, Inc. shareholders approved Approve the amendment and restatement of Workday’s 2012 Employee Stock Purchase Plan to increase the number of shares of common stock reserved for issuance at the 2026-06-16 meeting.
“Stockholders approved the amendment and restatement of Workday’s 2012 Employee Stock Purchase Plan to increase the number of shares of common stock reserved for issuance. The voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes 572,163,189 53,758,669 360,023 21,155,889”
WDAYWorkday, Inc.
Workday, Inc. shareholders approved Approve the amendment and restatement of Workday’s 2022 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance at the 2026-06-16 meeting.
“Stockholders approved the amendment and restatement of Workday’s 2022 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance. The voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes 568,193,373 57,658,923 429,585 21,155,889”
WDAYWorkday, Inc.
Workday, Inc. shareholders approved Approve, on an advisory basis, the compensation paid to Workday’s named executive officers at the 2026-06-16 meeting.
“Stockholders approved, on an advisory basis, the compensation paid to Workday’s named executive officers. The voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes 548,387,515 77,467,758 426,608 21,155,889”
WDAYWorkday, Inc.
Workday, Inc. shareholders approved Ratify the appointment of Ernst & Young LLP as Workday’s independent registered public accounting firm for the fiscal year ending January 31, 2027 at the 2026-06-16 meeting.
“Stockholders ratified the appointment of Ernst & Young LLP as Workday’s independent registered public accounting firm for Workday’s fiscal year ending January 31, 2027. The voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes 643,771,793 3,099,109 566,868 –”
WDAYWorkday, Inc.
Workday, Inc. shareholders approved Election of four Class II directors: Wayne A.I. Frederick, M.D., Mark J. Hawkins, Rhonda J. Morris, and George J. Still, Jr. at the 2026-06-16 meeting.
“The nominees for director proposed by Workday were elected to serve until Workday’s 2029 Annual Meeting of Stockholders and until their successors are elected and qualified, subject to earlier resignation or removal. The voting results were as follows: Director Name Votes For Votes Against Abstentions Broker Non-Votes Wayne A.I. Frederick, M.D. 531,480,982 94,397,373 403,526 21,155,889 Mark J. Hawkins 584,200,864 41,471,020 609,997 21,155,889 Rhonda J. Morris 621,425,341 4,438,163 418,377 21,155,889 George J. Still, Jr. 606,786,671 19,039,685 455,525 21,155,889”
ASBPAspire Biopharma Holdings, Inc.
Aspire Biopharma Holdings, Inc. shareholders approved To approve voluntary adjustments to the exercise price of the warrants (Exercise Price Adjustment Proposal) at the 2026-06-16 meeting.
“The number of shares that voted for, against, and withheld from voting for this Exercise Price Adjustment Proposal is summarized in the table below: Votes Non-Votes 1,739,702 110,483 4,839 0”
ASBPAspire Biopharma Holdings, Inc.
Aspire Biopharma Holdings, Inc. shareholders approved To approve adjustment of number of shares of common stock issuable upon exercise of warrants (Share Adjustment Proposal) at the 2026-06-16 meeting.
“The number of shares that voted for, against, and withheld from voting for this Share Adjustment Proposal is summarized in the table below: Votes Non-Votes 1,745,709 103,550 5,764 0”
ASBPAspire Biopharma Holdings, Inc.
Aspire Biopharma Holdings, Inc. shareholders approved To authorize issuance of shares of common stock upon exercise of warrants (Warrant Issuance Proposal) at the 2026-06-16 meeting.
“The number of shares that voted for, against, and withheld from voting for this Warrant Issuance Proposal is summarized in the table below: Votes Non-Votes 1,742,683 107,523 4,818 0”
BCPCBALCHEM CORP
BALCHEM CORP shareholders approved Advisory approval of the compensation of the Company's named executive officers at the 2026-06-18 meeting.
“Advisory approval of the compensation of the Company’s named executive officers: Votes For Votes Against Abstained Broker Non-Votes 26,636,456 554,019 38,037 1,934,748”
BCPCBALCHEM CORP
BALCHEM CORP shareholders approved Ratification of the appointment of RSM US LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-18 meeting.
“The ratification of the appointment of RSM US LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026: Votes For Votes Against Abstained 28,671,701 457,235 24,324”
BCPCBALCHEM CORP
BALCHEM CORP shareholders approved Election of two Class 3 director nominees to the Board of Directors to serve until the Annual Meeting of Shareholders in 2029 and until their successors are duly elected and qualified at the 2026-06-18 meeting.
“The election of two Class 3 director nominees to the Board of Directors to serve until the Annual Meeting of Shareholders in 2029 and until their successors are duly elected and qualified: Director Nominee Votes For Votes Against Abstained Broker Non-Votes David Fischer 25,318,402 1,877,390 22,720 1,934,748 Daniel Knutson 26,755,996 439,880 22,636 1,934,748”
TPTATerra Property Trust, Inc.
Terra Property Trust, Inc. shareholders approved Ratification of appointment of KPMG LLP as independent registered public accounting firm for fiscal year 2026 at the 2026-06-18 meeting.
“The stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the 2026 fiscal year. The votes with respect to the ratification of the appointment of KPMG LLP were as follows: Total Votes For Total Votes Against Abstentions Broker Non-Votes 11,781,421.172 793,255.908 521,005.691 0”
TPTATerra Property Trust, Inc.
Terra Property Trust, Inc. shareholders approved Election of five director nominees to serve until 2027 annual meeting at the 2026-06-18 meeting.
“The Company’s stockholders elected all five director nominees to serve until the 2027 annual meeting of stockholders and until their respective successors are duly elected and qualify. The votes with respect to the election of each of the five directors were as follows: Director Votes For Votes Withheld Broker Non-Votes Vikram S. Uppal 11,313,359.485 1,782,323.286 0 Roger H. Beless 11,413,366.251 1,682,316.520 0 Michael L. Evans 11,387,579.487 1,708,103.284 0 Spencer E. Goldenberg 11,413,928.411 1,681,754.360 0 Gaurav Misra 11,277,621.624 1,818,061.147 0”
SIDUSidus Space Inc.
Sidus Space Inc. shareholders rejected The amendment of the Company’s 2021 Omnibus Equity Incentive Plan to adopt an evergreen provision such that, beginning on January 1, 2027 and ending with the last January 1 during the initial ten-year term of the Plan, the share reserve under the 2021 Plan will be automatically increased by a number at the 2026-06-18 meeting.
“Proposal 4. The amendment of the Company’s 2021 Omnibus Equity Incentive Plan to adopt an evergreen provision such that, beginning on January 1, 2027 and ending with the last January 1 during the initial ten-year term of the Plan, the share reserve under the 2021 Plan will be automatically increased by a number of shares of our common stock equal to the lesser of (A) 5% of the aggregate number of shares of our common stock outstanding on the final day of the immediately preceding calendar year or (B) such smaller number of shares as is determined by our board of directors was not approved by the stockholders by the votes set forth in the table below: For Against Abstain Broker Non Vote 5,958,921 5,959,444 240,477 25,793,893”
SIDUSidus Space Inc.
Sidus Space Inc. shareholders approved The amendment of the Company’s 2021 Omnibus Equity Incentive Plan to increase the number of shares of Class A common stock reserved and available for awards thereunder to 4,800,000 from 800,000 was approved by the stockholders at the 2026-06-18 meeting.
“Proposal 3. The amendment of the Company’s 2021 Omnibus Equity Incentive Plan to increase the number of shares of Class A common stock reserved and available for awards thereunder to 4,800,000 from 800,000 was approved by the stockholders by the votes set forth in the table below: For Against Abstain Broker Non Vote 10,065,579 1,922,827 170,434 25,793,895”
SIDUSidus Space Inc.
Sidus Space Inc. shareholders approved The appointment of Fruci & Associates, PLLC as the Company’s independent registered public accounting firm for its fiscal year ended December 31, 2026 was ratified and approved by the stockholders at the 2026-06-18 meeting.
“Proposal 2. The appointment of Fruci & Associates, PLLC as the Company’s independent registered public accounting firm for its fiscal year ended December 31, 2026 was ratified and approved by the stockholders by the votes set forth in the table below: For Against Abstain Broker Non Vote 36,879,568 900,008 173,158 1”
SIDUSidus Space Inc.
Sidus Space Inc. shareholders approved All of the six (6) nominees for director were elected to serve until the 2027 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified, or until such director’s earlier resignation, removal or death. at the 2026-06-18 meeting.
“Proposal 1 . All of the six (6) nominees for director were elected to serve until the 2027 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified, or until such director’s earlier resignation, removal or death. The result of the votes to elect the six (6) directors was as follows: Directors For Against Abstain Broker Non Vote Carol Craig 11,588,678 0 570,166 25,793,891 Jeffrey Shuman 11,617,406 0 541,437 25,793,892 Tiffany Norwood 11,856,677 0 302,166 25,793,892 Kelle Wendling 11,868,381 0 290,463 25,793,891 Leonardo Riera 11,556,121 0 602,723 25,793,891 Lavanson Coffey III 11,417,673 0 741,169 25,793,892”
DALDELTA AIR LINES, INC.
DELTA AIR LINES, INC. shareholders rejected Shareholder proposal requesting the adoption of cumulative voting for the election of directors at the 2026-06-18 meeting.
“5. The shareholders did not approve a shareholder proposal requesting the adoption of cumulative voting for the election of directors: For Against Abstain Broker Non-Votes 20,465,549 489,358,644 7,307,512 75,289,096”
DALDELTA AIR LINES, INC.
DELTA AIR LINES, INC. shareholders rejected Shareholder proposal requesting the ability for shareholders to act by written consent at the 2026-06-18 meeting.
“4. The shareholders did not approve a shareholder proposal requesting the ability for shareholders to act by written consent: For Against Abstain Broker Non-Votes 160,742,873 349,243,354 7,145,478 75,289,096”
DALDELTA AIR LINES, INC.
DELTA AIR LINES, INC. shareholders approved Ratification of appointment of Ernst & Young LLP as independent auditors for 2026 at the 2026-06-18 meeting.
“3. The shareholders ratified the appointment of Ernst & Young LLP as the Company’s independent auditors for 2026: For Against Abstain Broker Non-Votes 567,469,129 24,576,694 374,978 Not Applicable”
DALDELTA AIR LINES, INC.
DELTA AIR LINES, INC. shareholders approved Advisory vote on executive compensation at the 2026-06-18 meeting.
“2. The shareholders approved the advisory vote on executive compensation: For Against Abstain Broker Non-Votes 503,418,157 13,127,616 585,932 75,289,096”
DALDELTA AIR LINES, INC.
DELTA AIR LINES, INC. shareholders approved Election of fourteen director nominees at the 2026-06-18 meeting.
“1. The shareholders elected all fourteen director nominees, each to serve as a member of the Company’s Board of Directors until the Company’s next annual meeting of shareholders and the election and qualification of his or her successor, or until such director’s earlier death, disqualification, resignation or removal: For Against Abstain Broker Non-Votes Edward H. Bastian 514,718,689 2,169,240 243,776 75,289,096 Christophe Beck 512,460,454 4,374,190 297,061 75,289,096 Maria Black 514,593,275 2,263,652 274,778 75,289,096 Willie CW Chiang 504,963,202 11,853,060 315,443 75,289,096 Greg Creed 510,093,374 6,716,384 321,947 75,289,096 David G. DeWalt 495,178,008 21,625,693 328,004 75,289,096 Leslie D. Hale 514,357,782 2,474,203 299,720 75,289,096 Christopher A. Hazleton 514,582,524 2,242,789 306,392 75,289,096 Michael P. Huerta 510,282,790 6,247,445 601,470 75,289,096 Judith J. McKenna 516,318,584 531,411 281,710 75,289,096 Vasant M. Prabhu 515,743,293 1,082,370 306,042 75,289,096 Sergio A.”
PEPGPepGen Inc.
PepGen Inc. shareholders approved Ratification of appointment of KPMG LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-18 meeting.
“Proposal 2 - Ratification of Appointment of Independent Registered Accounting Firm The Company’s stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. Votes For Votes Against Abstentions 54,556,255 77,083 17,507 There were zero broker non-votes regarding this proposal.”
PEPGPepGen Inc.
PepGen Inc. shareholders approved Election of three Class I directors to serve until the 2029 annual meeting at the 2026-06-18 meeting.
“Proposal 1 - Election of Directors The Company’s stockholders elected the three Class I directors to the Company’s board of directors, to serve until the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal. Director Nominee Votes For Votes Withheld Howard Mayer, M.D. 36,111,969 8,502,248 Joshua Resnick, M.D., M.B.A. 35,766,232 8,847,985 Lisa Wyman, M.S. 39,423,497 5,190,720 There were 10,036,628 broker non-votes regarding the election of each of Howard Mayer, Joshua Resnick, and Lisa Wyman.”
GAMEGameSquare Holdings, Inc.
GameSquare Holdings, Inc. shareholders approved Approval of a merger agreement with the Company’s wholly owned subsidiary for the purpose of restating the Certificate of Incorporation to, among other things, eliminate supermajority voting requirements to amend the Certificate of Incorporation, increase the number of authorized shares, declassify at the 2026-06-18 meeting.
“Proposal 4 – Approval of a merger agreement with the Company’s wholly owned subsidiary for the purpose of restating the Certificate of Incorporation to, among other things, eliminate supermajority voting requirements to amend the Certificate of Incorporation, increase the number of authorized shares, declassify the Board of Directors, and implement other non-material specified changes Votes For Votes Against Abstentions Broker Non-Votes 60,160,608 5,738,056 331,972 2,612,952”
GAMEGameSquare Holdings, Inc.
GameSquare Holdings, Inc. shareholders approved Approval, on a non-binding advisory basis, of the compensation of the Company’s named executive officers at the 2026-06-18 meeting.
“Proposal 3 – Approval, on a non-binding advisory basis, of the compensation of the Company’s named executive officers Votes For Votes Against Abstentions Broker Non-Votes 60,567,323 5,069,123 594,190 2,612,952”
GAMEGameSquare Holdings, Inc.
GameSquare Holdings, Inc. shareholders approved Ratification of the appointment of Kreston GTA as the Company’s independent registered public accounting firm to audit the Company’s financial statements for the fiscal year ending December 31, 2026 at the 2026-06-18 meeting.
“Proposal 2 – Ratification of the appointment of Kreston GTA as the Company’s independent registered public accounting firm to audit the Company’s financial statements for the fiscal year ending December 31, 2026 Votes For Votes Against Abstentions Broker Non-Votes 66,478,785 1,355,712 1,009,090 1”
GAMEGameSquare Holdings, Inc.
GameSquare Holdings, Inc. shareholders approved Election of Class II Members to Board of Directors at the 2026-06-18 meeting.
“Proposal 1 – Election of Class II Members to Board of Directors Nominee Votes For Votes Withheld Broker Non-Votes Justin Kenna 57,745,275 580,414 2,612,952 Stuart Porter 57,986,037 310,140 2,612,952”
METMETLIFE INC
METLIFE INC shareholders approved Advisory (non-binding) vote to approve the compensation paid to the Company's Named Executive Officers at the 2026-06-16 meeting.
“Advisory (non-binding) vote to approve the compensation paid to the Company's Named Executive Officers 519,208,384 29,698,510 1,391,751 42,002,376”
METMETLIFE INC
METLIFE INC shareholders approved Ratification of appointment of Deloitte & Touche LLP as the Company's independent auditor for 2026 at the 2026-06-16 meeting.
“Ratification of appointment of Deloitte & Touche LLP as the Company's Independent Auditor for 2026 557,226,053 34,799,734 275,234 N/A”
METMETLIFE INC
METLIFE INC shareholders approved Election of eleven directors for a term expiring at the 2027 annual meeting at the 2026-06-16 meeting.
“Election of Directors: Nominee Name Votes For Votes Against Abstained Broker Non-Votes Daniel S. Glaser 548,594,293 1,402,406 301,946 42,002,376 Carla A. Harris 531,093,856 18,882,222 322,567 42,002,376 Laura J. Hay 546,736,903 3,260,345 301,397 42,002,376 R. Glenn Hubbard, Ph.D. 527,371,205 22,608,371 319,069 42,002,376 Jeh C. Johnson 540,643,747 9,327,414 327,484 42,002,376 William E. Kennard 542,209,127 7,782,975 306,543 42,002,376 Michel A. Khalaf 548,618,537 1,357,430 322,678 42,002,376 Diana L. McKenzie 547,213,102 2,800,742 284,801 42,002,376 Christian S. Mumenthaler, Ph.D. 548,665,228 1,315,288 318,129 42,002,376 Michelle Seitz 548,256,661 1,742,224 299,760 42,002,376 Mark A. Weinberger 531,174,670 18,815,797 308,178 42,002,376”
FDMT4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc. shareholders approved Advisory, non-binding vote on named executive officers’ compensation at the 2026-06-17 meeting.
“Proposal 3. The Company’s stockholders approved, on an advisory, non-binding basis, the named executive officers’ compensation as disclosed in the Proxy Statement. FOR AGAINST ABSTAIN BROKER NON-VOTES 36,065,437 940,414 67,379 6,964,792”
FDMT4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc. shareholders approved Ratification of selection of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-17 meeting.
“Proposal 2. The Company’s stockholders ratified the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. FOR AGAINST ABSTAIN 43,900,362 55,763 81,897”
FDMT4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc. shareholders approved Election of Class III directors at the 2026-06-17 meeting.
“Proposal 1. The Company’s stockholders elected by a plurality of votes cast the Class III director nominees below to the Company’s Board of Directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected. NOMINEE FOR WITHHELD BROKER NON-VOTES Nancy Miller-Rich 35,880,028 1,193,202 6,964,792 John F. Milligan, Ph.D. 35,778,121 1,295,109 6,964,792 Shawn Cline Tomasello, MBA 30,508,706 6,564,524 6,964,792”
BFLYButterfly Network, Inc.
Butterfly Network, Inc. shareholders approved Advisory vote on executive compensation at the 2026-06-18 meeting.
“The Company’s stockholders approved by a non-binding advisory vote the compensation of the Company’s named executive officers, as disclosed in the proxy statement. The votes cast on this proposal were as follows: Votes For Votes Against Abstentions Broker Non-Votes 614,118,861 8,857,243 517,710 68,273,752”
BFLYButterfly Network, Inc.
Butterfly Network, Inc. shareholders approved Ratify the appointment of Deloitte & Touche LLP as independent registered public accounting firm at the 2026-06-18 meeting.
“The Company’s stockholders approved the proposal to ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The votes cast on this proposal were as follows: Votes For Votes Against Abstentions 690,013,905 1,037,128 716,533”
BFLYButterfly Network, Inc.
Butterfly Network, Inc. shareholders approved Election of Directors at the 2026-06-18 meeting.
“Each of Joseph DeVivo; Jonathan M. Rothberg, Ph.D.; Larry Robbins; Caroll H. Neubauer; Elazer Edelman, M.D., Ph.D.; S. Louise Phanstiel; and Erica Schwartz, M.D., J.D., M.P.H. was elected as a director of the Company, to serve for a one-year term until the Company’s 2026 Annual Meeting of Stockholders and until their respective successor has been elected and qualified. The votes cast in the election of the directors were as follows: Nominee Votes For Votes Against Abstentions Broker Non-Votes Joseph DeVivo 621,675,693 1,606,171 211,950 68,273,752 Jonathan M. Rothberg, Ph.D. 622,369,243 898,308 226,263 68,273,752 Larry Robbins 622,081,118 1,191,480 221,216 68,273,752 Caroll H. Neubauer 622,482,090 785,388 226,336 68,273,752 Elazer Edelman, M.D., Ph.D. 622,169,037 1,097,459 227,318 68,273,752 S. Louise Phanstiel 621,997,159 1,168,660 327,995 68,273,752 Erica Schwartz, M.D., J.D., M.P.H. 621,848,491 1,430,748 214,575 68,273,752”
PENPenumbra Inc
Penumbra Inc shareholders approved Approval, on an Advisory Basis, of the Compensation of the Company's Named Executive Officers at the 2026-06-18 meeting.
“The compensation of the Company’s named executive officers was approved, on an advisory basis, based on the following results of voting: Votes For Votes Against Abstentions Broker Non-Votes 24,113,038 762,612 34,741 4,350,292”
PENPenumbra Inc
Penumbra Inc shareholders approved Ratification of Selection of Independent Registered Public Accounting Firm at the 2026-06-18 meeting.
“The selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Penumbra for the fiscal year ending December 31, 2026 was ratified based on the following results of voting: Votes For Votes Against Abstentions Broker Non-Votes 29,208,244 42,529 9,910 N/A”
PENPenumbra Inc
Penumbra Inc shareholders approved Election of Class II Directors at the 2026-06-18 meeting.
“1) Election of Class II Directors . The following nominees were elected to serve as Class II directors until the Company’s 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified, or, if sooner, until the director’s death, resignation or removal, based on the following results of voting: Nominee Votes For Votes Withheld Broker Non-Votes Arani Bose, M.D. 21,137,932 3,772,459 4,350,292 Bridget O'Rourke 23,790,926 1,119,465 4,350,292 Surbhi Sarna 24,232,264 678,127 4,350,292”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.